Welcome to Hologic Investor Relations

Hologic, Inc. is an innovative medical technology company primarily focused on improving women's health and well-being through early detection and treatment.

The Company's Common Stock is listed on the Nasdaq Global Select Market under the trading symbol HOLX.

Recent and Upcoming Events
Wednesday, November 8, 2017
4:30pm - 5:30pm EST

Dial-in Numbers 866-548-4713 US/Canada +1 323-794-2039 International Passcode 7397739 Replay Click here to access replay

Recent News
Oct 17, 2017

Hologic, Inc. (Nasdaq: HOLX) announced today that it has received an additional European Medical Device Directive (MDD) certification for SculpSure®, a state-of-the-art body contouring laser...

Oct 11, 2017

LONDON, UK October 11, 2017 - New survey results released today highlight the considerable impact and lack of awareness of heavy periods, which affect one in five women. That’s over 4 million...

Oct 5, 2017

Hologic, Inc. (Nasdaq: HOLX) announced today that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for its Panther Fusion® Flu A/B/RSV assay running on...

Oct 4, 2017

Hologic, Inc. (NASDAQ: HOLX) announced today that it has priced its previously announced private offering of $350 million aggregate principal amount of 4.375% senior notes due 2025 at an issue...

More ›